Haemonetics (HAE) Tops Q2 EPS by 15c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $73.38 +1.17%
EPS Growth %: -0.9%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -0.9%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.83, $0.15 better than the analyst estimate of $0.68. Revenue for the quarter came in at $297.48 million versus the consensus estimate of $270.46 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
